Thyroid Medication Shortage UK

Current Active Shortages (0)

What to Do If Affected

• Ask the pharmacy whether the same levothyroxine strength, brand, or liquid formulation can be ordered from another supplier or nearby branch.
• Do not switch levothyroxine brand, tablet strength, liquid formulation, or dosing pattern without pharmacist, GP, or specialist guidance.
• Tell the pharmacist if you are pregnant, have thyroid cancer follow-up, have heart disease, or have recently had abnormal thyroid blood tests.
• If a brand or formulation change is unavoidable, ask the prescriber whether thyroid blood tests or follow-up are needed after the change.
• Request repeat prescriptions early enough to give the pharmacy time to source stock, but do not stockpile medicine beyond what your prescriber supplies.

Why the historical levothyroxine SSP still appears in searches

Many thyroid-shortage searches still mention levothyroxine 12.5 microgram tablets because NHSBSA published Serious Shortage Protocol SSP010 for that strength in 2021. The protocol allowed a defined pharmacy supply route for specific prescriptions while it was active. NHSBSA now lists SSP010 in its SSP archive with an end date of 1 April 2021, which means it should not be presented as a current national SSP.

If your local pharmacy cannot obtain levothyroxine, that may still be a real local stock problem. It is different from a live national SSP. The safest next step is to ask the pharmacist to check whether the same prescribed medicine can be sourced, whether another branch or wholesaler has stock, and whether the prescriber needs to review the prescription.

Levothyroxine stock problems need brand and dose care

Levothyroxine is a synthetic form of thyroxine used for underactive thyroid. NHS guidance says it replaces thyroxine when the thyroid gland cannot make enough. Patients often stay on a stable dose for long periods, so supply disruption can be stressful even when there is no national shortage notice.

Not every levothyroxine supply problem is solved by swapping boxes. Tablet strengths, liquid formulations, excipients, timing, pregnancy status, cardiac history, thyroid cancer follow-up, and recent blood-test results can matter. Some patients also report feeling different after manufacturer changes, so persistent symptoms after a switch should be discussed with a clinician rather than managed by changing the dose yourself.

If your pharmacy cannot fill levothyroxine

Start with the exact prescription details: active ingredient, strength, brand or manufacturer if specified, formulation, quantity, and how many doses remain. Ask the pharmacy whether the same item can be ordered, whether a different pack size is available, or whether another local pharmacy can supply the prescription.

If the pharmacy cannot source the prescribed item, ask whether they need the GP surgery, endocrinology team, or thyroid cancer team to issue a new prescription. Do not copy the historical SSP010 alternate-day approach unless a pharmacist confirms a current legal supply route or your prescriber explicitly changes the prescription for you.

When liothyronine needs specialist input

Liothyronine is not a routine substitute for levothyroxine. NHS England advice says liothyronine should only be prescribed when no alternative intervention or medicine is clinically appropriate or available. If you take liothyronine already, a shortage or local stock delay should normally be escalated through the prescriber or specialist who manages it.

If a pharmacy suggests that liothyronine is unavailable, ask them to confirm the exact product and strength affected, then contact the prescribing clinician. Do not start, stop, or replace liothyronine with levothyroxine unless the specialist or GP responsible for your thyroid care makes that plan.

Who should be escalated sooner

Some patients should not wait until the last tablet before seeking help. Escalate promptly if the medicine is for pregnancy, recent dose titration, thyroid cancer monitoring, congenital hypothyroidism, severe hypothyroid symptoms, heart rhythm or angina history, or a child. These groups may need faster clinician input if supply disruption risks missed doses or an unplanned formulation change.

Seek urgent medical advice if you become acutely unwell, have chest pain, severe palpitations, fainting, confusion, or symptoms that feel unsafe. MediWatch can track shortage signals, but it cannot decide whether a missed dose, switch, or symptom pattern is safe for you personally.

How MediWatch tracks thyroid shortage signals

This page is rebuilt from the same shortage feed used across MedWatch. A thyroid shortage card appears when an active official row matches levothyroxine, liothyronine, or thyroid-related terms. Expired rows are not counted as current active shortages, even if older documents remain online and continue to rank in search results.

For practical monitoring, add levothyroxine, liothyronine, and the exact brand or formulation you use to your MediWatch alerts. That gives you an early warning if a new DHSC Medicine Supply Notification, NHSBSA Serious Shortage Protocol, or relevant safety/supply signal appears.

Common Questions

Official Sources

Related Medicine Pages